Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 3, 2022
International Plasma Awareness Week 2022: Donate Locally. Think Globally.
ANNAPOLIS, MD (October 3, 2022) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the 10th annual International Plasma Awareness Week (IPAW), which will run from Monday, October 3 until Friday, October 7.
All
Press releases
Oct 3, 2022
International Plasma Awareness Week 2022: Donate Locally. Think Globally.
ANNAPOLIS, MD (October 3, 2022) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the 10th annual International Plasma Awareness Week (IPAW), which will run from Monday, October 3 until Friday, October 7.
All
Press releases
Sep 1, 2022
The Source Fall 2022
Magazine of the plasma protein therapeutics industry - Fall 2022
All
The Source magazine
https://uploads-ssl.webflow.com/638f893112c6eac0e46ac576/644fcd8639e6dc520969c141_The%20Source_Fall2022.pdf
Sep 1, 2022
The Source Fall 2022
Magazine of the plasma protein therapeutics industry - Fall 2022
All
The Source magazine
https://uploads-ssl.webflow.com/638f893112c6eac0e46ac576/644fcd8639e6dc520969c141_The%20Source_Fall2022.pdf
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).
All
PPTA statements
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
PPTA considers that the current MPXV outbreak is not a concern for the safety margins of plasma protein therapies manufactured by PPTA member companies. This assessment is also shared by other concerned parties (AABB, WHO).
All
PPTA statements
No results found